RECRUITING

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Quality of life data following SBRT for prostate cancer has been obtained in only a small numbers of patients. A prospective study using validated quality of life questionnaires is needed to determine outcomes after treatment with SBRT. Our study will be the first essential step in developing a better evidence base on the comparative risks and benefits of SBRT treatment with regards to quality of life assessment and outcomes.

Official Title

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)

Quick Facts

Study Start:2012-12
Study Completion:2025-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01766492

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Histologically confirmed adenocarcinoma of prostate
  2. * Signed study-specific consent
  3. * Prostate Specific Antigen (PSA) within 60 days of registration
  1. * Prior pelvic radiotherapy
  2. * Prior radical prostate surgery
  3. * Medical or psychiatric illness that would interfere with treatment or follow up
  4. * Implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and/or treatment delivery

Contacts and Locations

Study Contact

Malika T Danner
CONTACT
202-444-3068
mtd@georgetown.edu
Sean P Collins, MD, PhD
CONTACT
202-444-3292
spc9@gunet.georgetown.edu

Principal Investigator

Sean P Collins, MD, PhD
PRINCIPAL_INVESTIGATOR
Georgetown University Hospital

Study Locations (Sites)

Georgetown University Hospital
Washington, District of Columbia, 20007
United States

Collaborators and Investigators

Sponsor: Georgetown University

  • Sean P Collins, MD, PhD, PRINCIPAL_INVESTIGATOR, Georgetown University Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2012-12
Study Completion Date2025-04

Study Record Updates

Study Start Date2012-12
Study Completion Date2025-04

Terms related to this study

Keywords Provided by Researchers

  • prostate cancer
  • CyberKnife

Additional Relevant MeSH Terms

  • Prostate Cancer
  • Localized Malignant Neoplasm